Takada Y et al. |
Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation. |
2000 |
Transplant. Proc. |
pmid:10715416
|
Fukuoka T et al. |
Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion. |
1993 |
Transplant. Proc. |
pmid:8470175
|
Taniguchi S et al. |
Effects of a platelet-activating factor antagonist at different doses given simultaneously with double-filtration plasmapheresis on cardiac xenograft survival. |
1994 |
Transplant. Proc. |
pmid:8171719
|
Coughlan AF et al. |
In vivo studies of P-selectin and platelet activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection. |
1993 |
Transplant. Proc. |
pmid:7692651
|
Hammer C et al. |
Xenogeneic rejection mechanisms shown by intravital microscopy. |
1998 |
Transplant. Proc. |
pmid:9865335
|
Takada Y et al. |
Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist. |
1998 |
Transplant. Proc. |
pmid:9838621
|
Fukunaga K et al. |
Successful liver transplantation from non-heart-beating donors by blockade of endothelin and PAE. |
1998 |
Transplant. Proc. |
pmid:9838664
|
Lloberas N et al. |
The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury. |
2002 |
Transplant. Proc. |
pmid:11959179
|
Castellvi J et al. |
Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model. |
2002 |
Transplant. Proc. |
pmid:11959181
|
Keskinoglu A et al. |
Inflammatory lipid mediators and immunologic recognition in allogeneic renal transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9122948
|
Otte KE et al. |
Xenoperfusion of rabbit kidney and the impact of BN 52021: a specific antagonist of platelet-activating factor. |
1990 |
Transplant. Proc. |
pmid:2349668
|
Mahmoud FF et al. |
In vitro effects of ginkgolide B combined with cyclosporin A on T-lymphocyte activation and IL-5 expression in peripheral blood mononuclear cells from asthmatic subjects. |
2002 |
Transplant. Proc. |
pmid:12431672
|
Borobia FG et al. |
Platelet-activating factor antagonist BN52021 improves survival in normothermic liver ischemia in rats. |
1993 |
Transplant. Proc. |
pmid:8356661
|
Da Costa M et al. |
Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170. |
1990 |
Transplant. Proc. |
pmid:2389490
|
O'Hair DP et al. |
Platelet activating factor antagonist RP-59227 reduces vascular injury in discordant cardiac xenograft rejection. |
1992 |
Transplant. Proc. |
pmid:1566490
|
|
First International Alexis Carrel Conference on Lipid Mediators in Organ Transplantation. April 8-10, 1986, Washington, DC. |
1986 |
Transplant. Proc. |
pmid:3765055
|
Minor T et al. |
Treatment of preservation/reperfusion injury by platelet-activating factor antagonism in the rat liver graft. |
1995 |
Transplant. Proc. |
pmid:7879086
|
Ide S et al. |
Donor administration of PAF antagonist (TCV-309) enhances lung preservation. |
1995 |
Transplant. Proc. |
pmid:7879103
|
Takada Y et al. |
Platelet activating factor antagonist has a protective effect on preservation/reperfusion injury of the graft in pig liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7879169
|
Yin M et al. |
Beneficial effect of platelet-activating factor antagonist TCV-309 on renal ischemia-reperfusion injury. |
1995 |
Transplant. Proc. |
pmid:7879180
|